EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION STATUS: DOES YOUNGER MEAN MORE FREQUENTLY MUTATED?

被引:1
|
作者
Wojcik, P. [1 ]
Krawczyk, P. [2 ]
Chorostowska-Wynimko, J. [3 ]
Reszka, K. [4 ]
Duk, K. [3 ]
Muszczynska-Bernhard, B. [5 ]
Pankowski, J. [6 ]
Wojas-Krawczyk, K. [2 ]
Czyzewicz, G. [7 ]
Ramlau, R. [8 ]
Skoczek, M. [7 ]
Grenda, A. [2 ]
Orlowski, T. [3 ]
Grodzki, T. [9 ]
Piwowar, M. [10 ]
Roszkowski-Sliz, K. [3 ]
Milanowski, J. [2 ]
机构
[1] Oncogene Diagnost LLC, PL-31546 Krakow, Poland
[2] Med Univ Lublin, Dept Pneumonol Oncol & Allergol, PL-20950 Lublin, Poland
[3] Natl Inst TB & Lung Dis, PL-01138 Warsaw, Poland
[4] Genet & Immunol Lab Genim LLC, PL-20609 Lublin, Poland
[5] Lower Silesian Ctr Lung Dis, Dept Pathol, PL-53439 Wroclaw, Poland
[6] Pulm Hosp, Dept Pathol, PL-34500 Zakopane, Poland
[7] John Paul 2 Hosp, Dept Oncol, PL-31202 Krakow, Poland
[8] Poznan Univ Med Sci, Dept Clin Oncol, PL-61701 Poznan, Poland
[9] Pomeranian Med Univ, Dept Thorac Surg & Transplantat, PL-70204 Szczecin Zdunowo, Poland
[10] Jagiellonian Univ, Coll Med, Dept Bioinformat & Telemed, PL-31007 Krakow, Poland
关键词
CELL LUNG-CANCER; ADENOCARCINOMA;
D O I
10.1515/bjmg-2017-0029
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:89 / 90
页数:2
相关论文
共 50 条
  • [1] Microarray Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status
    LaFrance, D. R.
    Lowery-Nordberg, M.
    LABORATORY INVESTIGATION, 2010, 90 : 434A - 434A
  • [2] Microarray Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status
    LaFrance, D. R.
    Lowery-Nordberg, M.
    MODERN PATHOLOGY, 2010, 23 : 434A - 434A
  • [3] Epidermal Growth Factor Receptor Mutation and Chemosensitivity
    Matsubara, Daisuke
    Niki, Toshiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 771 - 772
  • [4] Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors
    Moiseenko, Fedor
    Kuligina, Ekaterina
    Elsakova, Ekaterina
    Imyanitov, Evgeny
    FUTURE ONCOLOGY, 2024, 20 (31) : 2397 - 2407
  • [5] Epidermal growth factor receptor expression status in lung cancer correlates with its mutation
    Suzuki, M
    Shigematsu, H
    Hiroshima, K
    Iizasa, T
    Nakatani, Y
    Minna, JD
    Gazdar, AF
    Fujisawa, T
    HUMAN PATHOLOGY, 2005, 36 (10) : 1127 - 1134
  • [6] Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
    Sharma, Saniya
    Gupta, Nalini
    Singh, Navneet
    Chaturvedi, Rini
    Behera, Digambar
    Rajwanshi, Arvind
    CYTOJOURNAL, 2018, 15
  • [7] Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?
    Drpa, Gordana
    Sreter, Katherina B.
    Manojlovic, Spomenka
    Kukulj, Suzana
    ANTI-CANCER DRUGS, 2018, 29 (03) : 281 - 285
  • [8] Epidermal growth factor receptor mutation in gastric cancer
    Liu, Zhimin
    Liu, Lina
    Li, Mei
    Wang, Zhaohui
    Feng, Lu
    Zhang, Qiuping
    Cheng, Shihua
    Lu, Shen
    PATHOLOGY, 2011, 43 (03) : 234 - 238
  • [9] Epidermal Growth Factor Receptor Mutation and Chemosensitivity Response
    Yoshimasu, Tatsuya
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 772 - 773
  • [10] SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma
    D'Haene, Nicky
    Le Mercier, Marie
    Salmon, Isabelle
    Mekinda, Zita
    Remmelink, Myriam
    Berghmans, Thierry
    ONCOLOGIST, 2019, 24 (01): : 9 - 13